Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Flagellum-associated coiled-coil domain-containing protein 1 (FLACC1 or ALS2CR12) is a protein encoded by the FLACC1 gene, primarily expressed in testicular tissue and localizing to sperm flagella, specifically the principal piece region. Despite its testis-specific expression and initial association with sperm structure, knockout studies in mice have shown FLACC1 is dispensable for fertility and viability, indicating redundancy or a non-essential role in spermatogenesis. While the gene symbol ALS2CR12 references its location in a genomic region linked to juvenile amyotrophic lateral sclerosis, current evidence suggests no direct mechanistic or disease link for FLACC1 with ALS or other disorders. There are no known drug interactions or therapeutic mechanisms associated with FLACC1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Flagellum-associated coiled-coil domain-containing protein 1 (FLACC1).